Author

Mourad Brahimi

Observed name: M. Brahimi

Institutions: University of Batna 1, University of Batna 2

Observed institutions: University of Batna 1, University Hospital of Oran, University of Batna 2

OpenAlex ID: A5065744880

A phase II trial of docetaxel and cisplatin combination in patients with locally advanced undifferentiated carcinoma of nasopharyngeal type (UCNT): Study update

2006 · M. Yamouni, K. A. Benhadji, et al. · Journal of Clinical Oncology · 3

Benefits of Neoadjuvant Hypofractionated Radiotherapy in the Treatment of Locally Advanced Adenocarcinomas

2017 · Mourad Abid, Mohamed Amine Mansouri, et al. · Journal of General Practice · 1

Benefits of hypofractionated radiotherapy in locally advanced adenocarcinoma’s treatment

2017 · Service de chirurgie carcinologique CAC Batna, Algérie, Mourad Abid, et al. · Batna Journal of Medical Sciences (BJMS)

Zenker’s diverticulum. Report of a case

2017 · Aissam Megaache, Zakia Kordjani, et al. · Batna Journal of Medical Sciences (BJMS)

A phase II trial of docetaxel and cisplatin combination in patients with locally advanced undifferentiated carcinoma of the nasopharynx: updated results

2005 · M. Yamouni, K. A. Benhadji, et al. · Journal of Clinical Oncology

Combination of docetaxel and cisplatin for recurrent nasopharyngeal carcinoma: Preliminary results

2005 · K. A. Benhadji, M. Yamouni, et al. · Journal of Clinical Oncology

A phase II trial of docetaxel and cisplatin combination in patients with locally advanced undifferentiated carcinoma of nasopharygeal type (UCNT)

2004 · M. Yamouni, Y. Beldjillali, et al. · Journal of Clinical Oncology

136 Phase II trial of docetaxel (D) and cisplatin (C) combination in locally advanced undifferentiated carcinoma of nasopharyngeal type (UCNT)

2003 · M. Yamouni, Y. Beldjillali, et al. · European Journal of Cancer Supplements

Works count: 8

Citation count: 4

H-index: 1

I10-index: